Quantitative Anti-HBc in Liver Pathological States in Patients with Chronic Hepatitis B Virus Infection.

Zhan-Qing ZhangBi-Sheng ShiWei LuDan-Ping LiuDan HuangYan-Ling Feng

Published in: The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale (2019)

Following hepatic aggravation of necroinflammation and progression of fibrosis, anti-HBc increases gradually in HBeAg-positive patients and continues to increase gradually in HBeAg-negative patients, which is a useful but unsatisfactory marker for monitoring pathological states.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
hepatitis b virus
prognostic factors
high resolution